ECSP23019850A - Agonistas duales glp-1/gip - Google Patents
Agonistas duales glp-1/gipInfo
- Publication number
- ECSP23019850A ECSP23019850A ECSENADI202319850A ECDI202319850A ECSP23019850A EC SP23019850 A ECSP23019850 A EC SP23019850A EC SENADI202319850 A ECSENADI202319850 A EC SENADI202319850A EC DI202319850 A ECDI202319850 A EC DI202319850A EC SP23019850 A ECSP23019850 A EC SP23019850A
- Authority
- EC
- Ecuador
- Prior art keywords
- glp
- dual agonists
- gip
- obesity
- gip dual
- Prior art date
Links
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 title abstract 2
- 239000000556 agonist Substances 0.000 title abstract 2
- 230000009977 dual effect Effects 0.000 title abstract 2
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 title 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 title 1
- 208000008589 Obesity Diseases 0.000 abstract 2
- 235000020824 obesity Nutrition 0.000 abstract 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
- 108010004460 Gastric Inhibitory Polypeptide Proteins 0.000 abstract 1
- 102100039994 Gastric inhibitory polypeptide Human genes 0.000 abstract 1
- 102400000322 Glucagon-like peptide 1 Human genes 0.000 abstract 1
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 abstract 1
- 101000886868 Homo sapiens Gastric inhibitory polypeptide Proteins 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a polipéptidos duales de acción prolongada agonistas del péptido 1 similar al glucagón y del polipéptido insulinotrópico dependiente de glucosa (GIP) humano que pueden usarse para tratar la diabetes mellitus tipo 2 (T2D), la diabetes con obesidad, la obesidad y la hiperlipidemia.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN202021045240 | 2020-10-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP23019850A true ECSP23019850A (es) | 2023-05-31 |
Family
ID=85131249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSENADI202319850A ECSP23019850A (es) | 2020-10-17 | 2023-03-21 | Agonistas duales glp-1/gip |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR123791A1 (es) |
| EC (1) | ECSP23019850A (es) |
-
2021
- 2021-10-14 AR ARP210102841A patent/AR123791A1/es unknown
-
2023
- 2023-03-21 EC ECSENADI202319850A patent/ECSP23019850A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR123791A1 (es) | 2023-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2023001960A2 (es) | Agonistas duales glp-1/gip | |
| CL2022003654A1 (es) | Agonistas dobles de glp-1/gip de acción prolongada | |
| ECSP17043648A (es) | Compuestos co-agonistas de gip y glp-1 | |
| MY197569A (en) | Gip/glp1 co-agonist compounds | |
| PE20200926A1 (es) | Peptidos analogos de incretina | |
| BR112023024968A2 (pt) | Tratamento da obesidade e distúrbios relacionados à obesidade | |
| CO2025001430A2 (es) | Agonista dual de glp-1/gip, método de preparación y uso del mismo | |
| MX2021005725A (es) | Tratamiento de la obesidad y sus complicaciones. | |
| MX2026000195A (es) | Triagonista de los receptores glp-1, gip y gcg y su uso | |
| ECSP23019850A (es) | Agonistas duales glp-1/gip | |
| MX2021012177A (es) | Usos terapeuticos de dulaglutida. | |
| MX2024007449A (es) | Agonistas triples peptidicos del gip, glp-1 y glp-2. | |
| CL2025002476A1 (es) | Anticuerpo contra gipr y su proteína de fusión con glp-1, su composición farmacéutica y aplicación |